Dewey Steadman | Head, IR |
Martine Rothblatt | Chairman & CEO |
Michael Benkowitz | President & COO |
Leigh Peterson | VP, Product Development |
James Edgemond | CFO & Treasurer |
Chris Shibutani | Cowen |
Eun Yang | Jefferies |
Hartaj Singh | Oppenheimer |
Jessica Fye | JPMorgan |
Liana Moussatos | Wedbush Securities |
Martin Auster | Credit Suisse |
Good morning, and welcome to the United Therapeutics Corporation First Quarter 2020 Earnings Call. My name is Mariana, and I will be your conference operator today. [Operator Instructions].
I will now turn the conference call over to Mr. Dewey Steadman, Head of Investor Relations of United Therapeutics.